Phage treatment of multidrug-resistant bacterial infections in humans, animals, and plants: The current status and future prospects

Highlights • Phage therapy targets multidrug-resistant bacterial infections.• Offers advantages like biofilm disruption and microbiota preservation.• Provides benefits compared to antibiotics by preserving the host's microbiota.• Potential to serve as a replacement or complement for antibiotics.• Faces challenges like narrow host range and regulatory hurdles.• Future optimizations include phage cocktails and genetic modifications.

• Publication year

  2025

• Venue

  Infectious Medicine

• Publication date

  2025-02-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.imj.2025.100168PMID 40104270PMCID 11919290
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Positive and negative aspects of bacteriophages and their immense role in the food chain

  2024cited by this paper
• Bacteriophages as Nanocarriers for Targeted Drug Delivery and Enhanced Therapeutic Effects

  2024cited by this paper
• Phage therapy could be key to conquering persistent bacterial lung infections in children

  2024cited by this paper
• Phage therapy: A novel approach against multidrug-resistant pathogens

  2024cited by this paper
• Current status of clinical trials for phage therapy

  2024cited by this paper
• Bacteriophages: Sustainable and effective solution for climate-resilient agriculture

  2024cited by this paper
• A Comprehensive Review on Phage Therapy and Phage-Based Drug Development

  2024cited by this paper
• Evaluation of lyophilized bacteriophage cocktail efficiency against multidrug-resistant Salmonella in broiler chickens

  2024cited by this paper
• Role of bacteriophages in shaping gut microbial community

  2024cited by this paper
• Genetically engineered phages and engineered phage-derived enzymes to destroy biofilms of antibiotics resistance bacteria

  2024cited by this paper
• Novel lytic bacteriophage AhFM11 as an effective therapy against hypervirulent Aeromonas hydrophila

  2024cited by this paper
• Emerging roles of bacteriophage-based therapeutics in combating antibiotic resistance

  2024cited by this paper
• The growing repertoire of phage anti-defence systems.

  2024cited by this paper
• The use of phages for the biosynthesis of metal nanoparticles and their biological applications: A review

  2024cited by this paper
• Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study

  2024cited by this paper
• Microbial infections in burn patients

  2024cited by this paper
• Current Knowledge and Perspectives of Phage Therapy for Combating Refractory Wound Infections

  2024cited by this paper
• Making the leap from technique to treatment — genetic engineering is paving the way for more efficient phage therapy

  2024cited by this paper
• Protocol for phage matching, treatment, and monitoring for compassionate bacteriophage use in non-resolving infections

  2024cited by this paper
• Medicinal and immunological aspects of bacteriophage therapy to combat antibiotic resistance

  2024cited by this paper
• Phage-specific immunity impairs efficacy of bacteriophage targeting Vancomycin Resistant Enterococcus in a murine model

  2024cited by this paper
• Antimicrobial resistance of Pseudomonas aeruginosa: navigating clinical impacts, current resistance trends, and innovations in breaking therapies

  2024cited by this paper
• Phage Delivery Strategies for Biocontrolling Human, Animal, and Plant Bacterial Infections: State of the Art

  2024cited by this paper
• Gut phageome: challenges in research and impact on human microbiota

  2024cited by this paper
• How Phage Therapy Works, Its Advantages and Disadvantages: Mini Review

  2024cited by this paper
• Current and future directions in bacteriophage research for developing therapeutic innovations

  2024cited by this paper
• Optimized preparation pipeline for emergency phage therapy against Pseudomonas aeruginosa at Yale University

  2024cited by this paper
• Characterization of phage evolution and phage resistance in drug-resistant Stenotrophomonas maltophilia

  2024cited by this paper
• The Potential of Bacteriophage Therapy as an Alternative Treatment Approach for Antibiotic-Resistant Infections

  2023cited by this paper
• Improving phage therapy by evasion of phage resistance mechanisms

  2023cited by this paper
• Phage therapy: Targeting intestinal bacterial microbiota for the treatment of liver diseases

  2023cited by this paper
• Disruption of Biofilm by Bacteriophages in Clinically Relevant Settings.

  2023cited by this paper
• Assessing the environmental biosafety of phage-based biocontrol applications

  2023cited by this paper
• Regulations of phage therapy across the world

  2023cited by this paper
• The Biotechnological Application of Bacteriophages: What to Do and Where to Go in the Middle of the Post-Antibiotic Era

  2023cited by this paper
• Advanced strategies to overcome the challenges of bacteriophage-based antimicrobial treatments in food and agricultural systems

  2023cited by this paper
• Genetic Engineering and Biosynthesis Technology: Keys to Unlocking the Chains of Phage Therapy

  2023cited by this paper
• Effects of bacteriophage on Salmonella Enteritidis infection in broilers

  2023cited by this paper
• Bacteriophage strategies for overcoming host antiviral immunity

  2023cited by this paper
• Myriad applications of bacteriophages beyond phage therapy

  2023cited by this paper
• An overview of the use of bacteriophages in the poultry industry: Successes, challenges, and possibilities for overcoming breakdowns

  2023cited by this paper
• CRISPR-Cas9 mediated phage therapy as an alternative to antibiotics

  2023cited by this paper
• Advancements in bacteriophage therapies and delivery for bacterial infection

  2023cited by this paper
• [Research progress of phage therapy in orthopedic implant-related infection].

  2023cited by this paper
• Designing phage cocktails to combat the emergence of bacteriophage-resistant mutants in multidrug-resistant Klebsiella pneumoniae

  2023cited by this paper
• Phage Therapy—Challenges, Opportunities and Future Prospects

  2023cited by this paper
• Nano-emulsion encapsulation for the efficient delivery of bacteriophage therapeutics.

  2023cited by this paper
• Knowing and Naming: Phage Annotation and Nomenclature for Phage Therapy

  2023cited by this paper
• Bacteriophages and Their Host Range in Multidrug-Resistant Bacterial Disease Treatment

  2023cited by this paper
• Phage Therapy: A Different Approach to Fight Bacterial Infections

  2022cited by this paper
• Phage Therapy: A Different Approach to Fight Bacterial Infections

  2022cited by this paper
• The Spread of Antibiotic Resistance Genes In Vivo Model

  2022cited by this paper
• Biological foundations of successful bacteriophage therapy

  2022cited by this paper
• Bacteriophage and endolysin engineering for biocontrol of food pathogens/pathogens in the food: recent advances and future trends

  2022cited by this paper
• Treating bacterial infections with bacteriophages in the 21st century

  2022cited by this paper
• Phages against Pathogenic Bacterial Biofilms and Biofilm-Based Infections: A Review

  2022cited by this paper
• Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far

  2022cited by this paper
• Considerations for the Use of Phage Therapy in Clinical Practice

  2022cited by this paper
• Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review.

  2022cited by this paper
• Application of Lytic Bacteriophages and Their Enzymes to Reduce Saprophytic Bacteria Isolated from Minimally Processed Plant-Based Food Products—In Vitro Studies

  2022cited by this paper
• A perfect fit: Bacteriophage receptor-binding proteins for diagnostic and therapeutic applications.

  2022cited by this paper
• Bacteriophage-encoded enzymes destroying bacterial cell membranes and walls, and their potential use as antimicrobial agents.

  2021cited by this paper
• Temperate Phages, Prophages, and Lysogeny

  2021cited by this paper
• Overcoming Challenges to Make Bacteriophage Therapy Standard Clinical Treatment Practice for Cystic Fibrosis

  2021cited by this paper
• Animal Models of Phage Therapy

  2021cited by this paper
• Pseudomonas aeruginosa Resistance to Bacteriophages and Its Prevention by Strategic Therapeutic Cocktail Formulation

  2021cited by this paper
• Rapid Methods for Antimicrobial Resistance Diagnostics

  2021cited by this paper
• Preclinical data and safety assessment of phage therapy in humans

  2021cited by this paper
• Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future

  2021cited by this paper
• Phage Therapy in Livestock and Companion Animals

  2021cited by this paper
• The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies

  2021cited by this paper
• Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS) Analysis for the Identification of Pathogenic Microorganisms: A Review

  2021cited by this paper
• Bacteriophage endolysins against gram-positive bacteria, an overview on the clinical development and recent advances on the delivery and formulation strategies

  2021cited by this paper
• A combination therapy of Phages and Antibiotics: Two is better than one

  2021cited by this paper
• Genistein Inhibits the Pathogenesis of Aeromonas hydrophila by Disrupting Quorum Sensing Mediated Biofilm Formation and Aerolysin Production

  2021cited by this paper
• Antibiotic resistance genes in bacteria: Occurrence, spread, and control

  2021cited by this paper
• Microbial Resistance

  2021cited by this paper
• Phage therapeutics: from promises to practices and prospectives

  2021cited by this paper
• Uses of Bacteriophages as Bacterial Control Tools and Environmental Safety Indicators

  2021cited by this paper
• Engineering therapeutic phages for enhanced antibacterial efficacy.

  2021cited by this paper
• Bacteriophages: Combating Antimicrobial Resistance in Food-Borne Bacteria Prevalent in Agriculture

  2021cited by this paper
• Editorial: Manufacturing, Formulation and Delivery Issues for Phage Therapy to Become A Reality

  2020cited by this paper
• Growing Trend of Fighting Infections in Aquaculture Environment—Opportunities and Challenges of Phage Therapy

  2020cited by this paper
• Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?

  2020cited by this paper
• How Phages Overcome the Challenges of Drug Resistant Bacteria in Clinical Infections

  2020cited by this paper
• The Preclinical and Clinical Progress of Bacteriophages and Their Lytic Enzymes: The Parts are Easier than the Whole

  2019cited by this paper
• Phage Therapy in the Postantibiotic Era

  2019cited by this paper
• Engineered bacteriophages for treatment of a patient with a disseminated drug resistant Mycobacterium abscessus

  2019cited by this paper
• Phage Therapy with a Focus on the Human Microbiota

  2019cited by this paper
• Biological challenges of phage therapy and proposed solutions: a literature review

  2019cited by this paper
• Improved lyophilization conditions for long-term storage of bacteriophages

  2019cited by this paper
• Understanding and Exploiting Phage–Host Interactions

  2019cited by this paper
• Dynamic Modulation of the Gut Microbiota and Metabolome by Bacteriophages in a Mouse Model

  2019cited by this paper
• Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient

  2019cited by this paper
• Phages for Phage Therapy: Isolation, Characterization, and Host Range Breadth

  2019cited by this paper
• CFTR Protects against Mycobacterium abscessus Infection by Fine-Tuning Host Oxidative Defenses

  2019cited by this paper
• Antibiotic resistance: a rundown of a global crisis

  2018cited by this paper
• Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy

  2018cited by this paper
• Bacteriophage Therapy

  2018cited by this paper
• Semi-Solid and Solid Dosage Forms for the Delivery of Phage Therapy to Epithelia

  2018cited by this paper

• Bacteriophage-Based Control of Methicillin-Resistant Staphylococcus aureus: Anti-Biofilm Activity, Surface-Active Formulation Compatibility, and Genomic Context.

  2026cites this paper
• Environmental and public health risks of antibiotic resistance gene pollution in poultry systems: Sustainability impact, transmission pathways, and mitigation strategies

  2026cites this paper
• Phage biobanks as enabling infrastructure for precision phage therapy in the era of antimicrobial resistance.

  2026cites this paper
• Genomic analysis of five new mycobacteriophages belonging to the F, G, K, and P clusters

  2025cites this paper
• Isolation and characterization of multi-drug-resistant Microbacterium esteraromaticum bacteriophage: assessment of antibacterial efficacy and genomic insights

  2025cites this paper
• Bacteriophages as sustainable and eco-friendly alternatives for managing plant diseases: Brief review

  2025cites this paper
• Latest Advances in Inhalable Dry Powder Bacteriophage Therapy for Pulmonary Infections

  2025cites this paper
• Role of the Virome in Vaccine-Induced Immunization

  2025cites this paper
• Is a Bacteriophage Approach for Musculoskeletal Infection Management an Alternative to Conventional Therapy?

  2025cites this paper
• Engineered Phage-Guided Nanotherapeutic Systems for Precision Antibacterial Therapy: Hacking Bacterial Resistance Mechanisms

  2025cites this paper
• Novel bacteriophages effectively target multidrug-resistant clinical isolates of Klebsiella pneumoniae

  2025cites this paper
• Bacteriophage Therapy in Intensive Care Units: A Targeted Strategy to Combat Multidrug-Resistant Infections – A Review

  2025cites this paper
• Phage Therapy in Managing Multidrug-Resistant (MDR) Infections in Cancer Therapy: Innovations, Complications, and Future Directions

  2025cites this paper
• Leveraging machine learning to predict bacterial population dynamics and address antimicrobial resistance

  2025cites this paper
• Bacteriophage endolysins.

  2025cites this paper
• Advances in combating antimicrobial resistance in MRSA: a comprehensive review on nanotechnology and phage therapy

  2025cites this paper
• Harnessing phages to tackle antimicrobial resistance: a Saudi Arabian perspective

  2025cites this paper
• More Is Not Always Better: Co-Occurrence Analysis of Anti-Phage Systems Reveals Prevalent Neutral Interactions in P. aeruginosa

  2025cites this paper
• Genomic, Functional, and Evolutionary Insights into a Novel T7-like Phage B1 Infecting Multidrug-Resistant Enterobacter cloacae

  2025cites this paper
• Bacteriophages in Hip and Knee Periprosthetic Joint Infections: A Promising Tool in the Era of Antibiotic Resistance

  2025cites this paper
• Bacteriophages as a Sustainable Tool for Plant Disease Management: Benefits and Challenges

  2025cites this paper
• Pharmacological Modulation of the Gut Microbiota and Endotoxaemia: A Next-Generation Approach to Treating Metabolic Syndrome

  2025cites this paper
• Phage therapy modulates the gut microbiome and immune responses in non-typhoidal Salmonella-induced colitis.

  2025cites this paper
• World Journal of Clinical Pediatrics

  year unknowncites this paper